Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	28.85	61.58	9.24	20.99	55.89	63.83
Short-Term Investments	162.73	165.34	-	22.76	-	-
Cash & Short-Term Investments	191.58	226.92	9.24	43.76	55.89	63.83
Cash Growth	-34.59%	2356.33%	-78.89%	-21.71%	-12.44%	2568.39%
Accounts Receivable	0.23	0.12	1.17	1.36	1.61	2.01
Other Receivables	-	-	-	6.11	-	-
Total Trade Receivables	0.23	0.12	1.17	7.47	1.61	2.01
Inventory	-	-	-	-	1.4	0.98
Other Current Assets	4.16	4.13	6.43	1.99	0.44	0.48
Total Current Assets	195.96	231.16	16.84	53.22	59.33	67.3
Net Property, Plant & Equipment	64.37	59.54	6.32	0.37	2.49	2.73
Other Intangible Assets	50	50	50	-	-	-
Goodwill	-	-	24.06	-	-	-
Other Long-Term Assets	0.4	0.41	0.67	4.51	2.62	0.39
Total Assets	310.73	341.1	97.89	58.09	64.44	70.42
Accounts Payable	7.05	10.34	6.91	1.54	0.97	0.73
Accrued Expenses	5.04	5.48	3.59	1.3	1.03	0.82
Short-Term Debt	0.05	0.05	0.05	-	-	-
Current Portion of Leases	0.85	0.96	0.05	-	0.27	0.25
Unearned Revenue	-	1.4	-	-	-	-
Other Current Liabilities	-	-	5.07	0.28	-	-
Total Current Liabilities	12.99	18.23	15.66	3.12	2.27	1.8
Long-Term Debt	1.6	1.63	1.68	-	-	-
Long-Term Leases	1.07	1.43	0.78	-	0.26	0.52
Other Long-Term Liabilities	29.38	29.15	4.59	0.33	0.64	0.69
Total Long-Term Liabilities	32.05	32.2	7.05	0.33	0.9	1.21
Total Liabilities	45.03	50.43	22.71	3.45	3.16	3.01
Common Stock	0.07	0.07	0.03	0.14	0.14	0.14
Additional Paid-in Capital	537	522.37	227.59	160.43	159.73	158.59
Accumulated Other Comprehensive Income	0	-0.05	-	-	-	-
Retained Earnings	-271.38	-231.72	-152.44	-105.93	-98.6	-91.33
Shareholders' Equity	265.69	290.67	75.18	54.64	61.28	67.41
Total Liabilities & Equity	310.73	341.1	97.89	58.09	64.44	70.42
Total Debt	3.57	4.06	2.55	0	0.52	0.78
Net Cash (Debt)	188.01	222.85	6.69	43.76	55.37	63.05
Net Cash Growth	-15.64%	3232.64%	-84.72%	-20.97%	-12.19%	4445.93%
Net Cash Per Share	2.61	3.46	0.25	3.08	3.90	6.07
Book Value	265.69	290.67	75.18	54.64	61.28	67.41
Book Value Per Share	3.69	4.51	2.81	3.85	4.32	6.49
Tangible Book Value	215.69	240.67	1.12	54.64	61.28	67.41
Tangible Book Value Per Share	2.99	3.74	0.04	3.85	4.32	6.49

Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q